Deciphering mechanisms of COVID-19 induced anosmia
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$202,500Funder
National Institutes of Health (NIH)Principal Investigator
PendingResearch Location
United States of AmericaLead Research Institution
COLUMBIA UNIVERSITY HEALTH SCIENCESResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
Data Management and Data Sharing
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Project Summary/Abstract In this Competitive Revision proposal, we seek to investigate the non-cell autonomous effects of Covid-19 infections in olfaction. Our preliminary data suggest that induction of pro-inflammatory/antiviral pathwaysresult in disruption of inter-chromosomal genomic interactions, and downregulation of Olfactory Receptor (OR)gene expression. Since antiviral responses are expected be elicited upon Covid-19 infection, we hypothesizethat disruptions in nuclear architecture and OR expression account for the reported olfactory deficits in infectedpatients. Thus, we propose to analyze human autopsies of the olfactory epithelium, to decipher whether Covid-19 infections disrupt genomic interactions required for OR transcription. We will complement our studies inhuman autopsies with experiments using mice infected with SARS-CoV-2. RNA-seq, in situ HiC andimmunohistochemistry experiments in human and mice will reveal the molecular mechanisms by which Covid-19 induces olfactory dysfunction. Our experiments will provide critical insight to the mechanisms by which thevirus hijacks molecular and physiological processes of the host cell, opening new potential avenues for theprevention, diagnosis and treatment of Covid-19 infection.